Thomas Arne
Foot Surgery · Winston Salem, NCNPI 1508814633
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,665 of the $19,848 with a category attached, or 84.0%. Novartis accounts for 98.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $19,137 and has fallen 99.5% since, to $90 in 2025.
Across 18 payments — averaging $1102.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$20K
- Treace Medical Concepts, Inc.$133
- Boston Scientific$27
- Acera Surgical, Inc.$24
- AbbVie$22
- Lifenet Health$17
What the payments were for
- Speaking & faculty fees$16,66584%
- Travel & lodging$2,43812%
- Food & beverage$7464%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 13 | $19,625 |
| Treace Medical Concepts, Inc. | 1 | $133 |
| Boston Scientific | 1 | $27 |
| Acera Surgical, Inc. | 1 | $24 |
| AbbVie | 1 | $22 |
| Lifenet Health | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTRESTO$19,593
- Lapiplasty System$133
How this compares
Too few foot surgery providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 170 | $1,524 |
| Ketoconazole | 41 | $917 |
| Ammonium Lactate | 23 | $644 |
| Cephalexin | 57 | $532 |
| Pregabalin | 24 | $448 |
| Terbinafine Hcl | 40 | $379 |
| Doxycycline Hyclate | 39 | $374 |
| Colchicine | 16 | $310 |
| Silver Sulfadiazine | 33 | $306 |
| Ciclopirox | 13 | $306 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 40 | $255 |
| Mupirocin | 25 | $241 |
| SsdSilver Sulfadiazine | 17 | $231 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $182 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $120 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Winston Salem
- Sonya CatesWinston Salem$41
- Robert KleinEden$5K
- Bryan SatterwhiteShallotte$4K
- Christopher YoungWilmington$3K
- Scott BasingerCharlotte$2K
- Bennett EvansFayetteville$1K
- Reagan ParrishMorehead City$733
- Devin RicksFayetteville$472
- Tori Simmons LewisCharlotte$370
- Rosemary MichelFayetteville$163
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.